![tetracosamide atc4 tetracosamide atc4](https://www.mdpi.com/molecules/molecules-26-01202/article_deploy/html/images/molecules-26-01202-sch010-550.jpg)
In the UK tetracosactide is used for short-term therapy in conditions for which glucocorticoids are usually used but for some reason should not be some uses include use for people who don't respond to glucocorticoids or cannot tolerate them who have ulcerative colitis, Crohn's disease, juvenile rheumatoid arthritis, rheumatoid arthritis, or osteoarthrosis.
#TETRACOSAMIDE ATC4 SKIN#
In the US corticotropin is used to treat epileptic spasms in infants, acute exacerbations of multiple sclerosis in adults acute episodes of psoriatic arthritis and rheumatoid arthritis and ankylosing spondylitis in acute exacerbations or as maintenance therapy for collagen disorders like systemic lupus erythematosus and systemic dermatomyositis for skin conditions like severe erythema multiforme and Stevens–Johnson syndrome for serum sickness for severe acute and chronic allergic and inflammatory processes involving the eye such as keratitis, iritis and iridocyclitis, diffuse posterior uveitis, choroiditis, optic neuritis, chorioretinitis, and anterior segment inflammation sarcoidosis in the lungs and to treat edema in certain nephrotic syndromes. In the US the tetracosactide label is limited to diagnosis but the UK label provides for therapeutic uses. īoth corticotropin and tetracosactide have been used for therapeutic purposes. However, as of 2015 the US label for corticotropin does not include diagnostic use. the last portion (3 digits) identifies the active ingredient group strength.
![tetracosamide atc4 tetracosamide atc4](https://ars.els-cdn.com/content/image/1-s2.0-S0223523418309103-fx1.jpg)
![tetracosamide atc4 tetracosamide atc4](https://media.springernature.com/original/springer-static/image/chp%3A10.1007%2F978-981-10-6739-6_126-1/MediaObjects/427784_0_En_126-1_Sch2_HTML.png)
The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). Drugs are divided into different groups according to the organ or system on which they act and their chemical, pharmacological and therapeutical properties. The purpose of the World Health Organization (WHO) Anatomical Therapeutic Chemical ( ATC) classification system is to be used as a tool for drug utilization research in order to improve quality of drug use. The American Hospital Formulary Service permits an easy review of information on a group of drugs with similar activities and uses and allows the reader to determine quickly the similarities and differences among drugs within a group. The earliest marketed date recorded in the Drug Product Database. Same active ingredient group number Footnotes Footnote 1